A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.